FRIDAY, Jan. 26, 2018 — Lutathera (lutetium Lu 177 dotatate) is the first radioactive drug to be approved by the U.S. Food and Drug Administration to treat certain cancers of the gastrointestinal tract and pancreas, the agency said Friday in a news…Original Article
Lutathera Approved for Some Gastro and Pancreatic Cancers
